AGIO icon

Agios Pharmaceuticals

168 hedge funds and large institutions have $1.34B invested in Agios Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 62 increasing their positions, 48 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

2.26% more ownership

Funds ownership: 105.77%108.03% (+2.3%)

8% less capital invested

Capital invested by funds: $1.46B → $1.34B (-$118M)

18% less call options, than puts

Call options by funds: $4.89M | Put options by funds: $5.99M

Holders
168
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.89M
Puts
$5.99M
Net Calls
Net Calls Change

Top Buyers

1 +$31.6M
2 +$14.7M
3 +$14.3M
4
Morgan Stanley
Morgan Stanley
New York
+$13.7M
5
CP
Caligan Partners
New York
+$9.73M

Top Sellers

1 -$115M
2 -$12.4M
3 -$4.97M
4
Goldman Sachs
Goldman Sachs
New York
-$4.4M
5
Ameriprise
Ameriprise
Minnesota
-$4.19M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$123M
2
$111M
3
$92.8M
4
$89.3M
5
$78.5M
6
$58.5M
7
$57.8M
8
$56.6M
9
$47.9M
10
$47M
11
$44.9M
12
$40.5M
13
$36.2M
14
$34.6M
15
$27.9M
16
$23.9M
17
$23.7M
18
$23.3M
19
$22M
20
$21.3M
21
$20.7M
22
$15.8M
23
$13.8M
24
$13.5M
25
$12.9M